Dana Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$516K Hold
980
0.01% 474
2026
Q1
$551K Hold
980
0.02% 460
2025
Q4
$663K Hold
980
0.02% 441
2025
Q3
$626K Hold
980
0.02% 444
2025
Q2
$526K Hold
980
0.02% 449
2025
Q1
$412K Hold
980
0.01% 470
2024
Q4
$405K Hold
980
0.01% 475
2024
Q3
$495K Hold
980
0.02% 449
2024
Q2
$477K Hold
980
0.02% 439
2024
Q1
$529K Sell
980
-60
-6% -$32.8K 0.02% 432
2023
Q4
$577K Buy
1,040
+60
+6% +$28.2K 0.03% 310
2023
Q3
$429K Hold
980
0.02% 331
2023
Q2
$492K Hold
980
0.02% 318
2023
Q1
$490K Hold
980
0.02% 312
2022
Q4
$400K Hold
980
0.02% 339
2022
Q3
$319K Hold
980
0.02% 353
2022
Q2
$344K Buy
+980
New +$400K 0.02% 362

Other funds holding IDXX

Dana Investment Advisors's IDXX Position: Q2 2026 in Review

Dana Investment Advisors held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 980 shares worth $516K. The position accounts for 0.01% of the portfolio, ranked #474.

Dana Investment Advisors first reported a position in IDXX in Q2 2022 and has held it in 17 quarters since. The position peaked at $663K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Dana Investment Advisors held 980 shares of Idexx Laboratories worth $516K as of Q2 2026.
  • Dana Investment Advisors left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.01% of Dana Investment Advisors's portfolio in Q2 2026, its #474 holding.
  • Dana Investment Advisors first reported a position in Idexx Laboratories in Q2 2022 and has held it in 17 quarters since.
  • Dana Investment Advisors's Idexx Laboratories position peaked at $663K in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.